Gastroesphageal Variceal Hemorrhage Induced by Metastatic Liver Tumor of Lung Cancer

Gastroesophageal variceal hemorrhage is a lethal complication of portal hypertension. Liver cirrhosis is often the principal cause of the portal hypertensive state. Malignant tumors coexist with portal hypertension in some cases. Non-small-cell lung cancer (NSCLC) is likely to become metastatic. Liv...

Full description

Bibliographic Details
Main Authors: Takayuki Honda, Hiroaki Kobayashi, Masafumi Saiki, Yusuke Sogami, Yoshihiro Miyashita, Naohiko Inase
Format: Article
Language:English
Published: Karger Publishers 2012-12-01
Series:Case Reports in Oncology
Subjects:
Online Access:http://www.karger.com/Article/FullText/345956
id doaj-deee6bbe26334654a4760314c02c2086
record_format Article
spelling doaj-deee6bbe26334654a4760314c02c20862020-11-24T21:06:15ZengKarger PublishersCase Reports in Oncology1662-65752012-12-015364465010.1159/000345956345956Gastroesphageal Variceal Hemorrhage Induced by Metastatic Liver Tumor of Lung CancerTakayuki HondaHiroaki KobayashiMasafumi SaikiYusuke SogamiYoshihiro MiyashitaNaohiko InaseGastroesophageal variceal hemorrhage is a lethal complication of portal hypertension. Liver cirrhosis is often the principal cause of the portal hypertensive state. Malignant tumors coexist with portal hypertension in some cases. Non-small-cell lung cancer (NSCLC) is likely to become metastatic. Liver is a frequent site of cancer metastasis, but diffuse hepatic sinusoidal metastasis is uncommon as a metastatic form of NSCLC. This report describes a patient with gastroesophageal variceal hemorrhage owing to a metastatic liver tumor of NSCLC. The patient, a male smoker with stage IV NSCLC, was free of any hepatitis viral infection and had no alcohol addiction. Liver dysfunction and liver disease had never been pointed out in his medical history. His tumor harbored an L858R epidermal growth factor receptor mutation. Gefitinib was initiated but had to be ceased because of interstitial lung disease. Sequential steroid therapy was effective and bevacizumab-containing chemotherapy was commenced. Both chemotherapy regimens produced favorable effects against the metastatic liver tumor, eliciting atrophic change regardless of the chemotherapy-free interval. One day the patient was admitted to our hospital because of black stool and hypotension. Upper gastrointestinal endoscopy revealed a beaded appearance of the gastroesophageal varix with bloody gastric contents. The portal hypertension might have been caused by changes in portal vein hemodynamics induced by the conformational changes underlying the favorable response of the liver tumor to molecular targeted chemotherapy and notable regression.http://www.karger.com/Article/FullText/345956Gastroesphageal varixLung cancerGefitinibBevacizumab
collection DOAJ
language English
format Article
sources DOAJ
author Takayuki Honda
Hiroaki Kobayashi
Masafumi Saiki
Yusuke Sogami
Yoshihiro Miyashita
Naohiko Inase
spellingShingle Takayuki Honda
Hiroaki Kobayashi
Masafumi Saiki
Yusuke Sogami
Yoshihiro Miyashita
Naohiko Inase
Gastroesphageal Variceal Hemorrhage Induced by Metastatic Liver Tumor of Lung Cancer
Case Reports in Oncology
Gastroesphageal varix
Lung cancer
Gefitinib
Bevacizumab
author_facet Takayuki Honda
Hiroaki Kobayashi
Masafumi Saiki
Yusuke Sogami
Yoshihiro Miyashita
Naohiko Inase
author_sort Takayuki Honda
title Gastroesphageal Variceal Hemorrhage Induced by Metastatic Liver Tumor of Lung Cancer
title_short Gastroesphageal Variceal Hemorrhage Induced by Metastatic Liver Tumor of Lung Cancer
title_full Gastroesphageal Variceal Hemorrhage Induced by Metastatic Liver Tumor of Lung Cancer
title_fullStr Gastroesphageal Variceal Hemorrhage Induced by Metastatic Liver Tumor of Lung Cancer
title_full_unstemmed Gastroesphageal Variceal Hemorrhage Induced by Metastatic Liver Tumor of Lung Cancer
title_sort gastroesphageal variceal hemorrhage induced by metastatic liver tumor of lung cancer
publisher Karger Publishers
series Case Reports in Oncology
issn 1662-6575
publishDate 2012-12-01
description Gastroesophageal variceal hemorrhage is a lethal complication of portal hypertension. Liver cirrhosis is often the principal cause of the portal hypertensive state. Malignant tumors coexist with portal hypertension in some cases. Non-small-cell lung cancer (NSCLC) is likely to become metastatic. Liver is a frequent site of cancer metastasis, but diffuse hepatic sinusoidal metastasis is uncommon as a metastatic form of NSCLC. This report describes a patient with gastroesophageal variceal hemorrhage owing to a metastatic liver tumor of NSCLC. The patient, a male smoker with stage IV NSCLC, was free of any hepatitis viral infection and had no alcohol addiction. Liver dysfunction and liver disease had never been pointed out in his medical history. His tumor harbored an L858R epidermal growth factor receptor mutation. Gefitinib was initiated but had to be ceased because of interstitial lung disease. Sequential steroid therapy was effective and bevacizumab-containing chemotherapy was commenced. Both chemotherapy regimens produced favorable effects against the metastatic liver tumor, eliciting atrophic change regardless of the chemotherapy-free interval. One day the patient was admitted to our hospital because of black stool and hypotension. Upper gastrointestinal endoscopy revealed a beaded appearance of the gastroesophageal varix with bloody gastric contents. The portal hypertension might have been caused by changes in portal vein hemodynamics induced by the conformational changes underlying the favorable response of the liver tumor to molecular targeted chemotherapy and notable regression.
topic Gastroesphageal varix
Lung cancer
Gefitinib
Bevacizumab
url http://www.karger.com/Article/FullText/345956
work_keys_str_mv AT takayukihonda gastroesphagealvaricealhemorrhageinducedbymetastaticlivertumoroflungcancer
AT hiroakikobayashi gastroesphagealvaricealhemorrhageinducedbymetastaticlivertumoroflungcancer
AT masafumisaiki gastroesphagealvaricealhemorrhageinducedbymetastaticlivertumoroflungcancer
AT yusukesogami gastroesphagealvaricealhemorrhageinducedbymetastaticlivertumoroflungcancer
AT yoshihiromiyashita gastroesphagealvaricealhemorrhageinducedbymetastaticlivertumoroflungcancer
AT naohikoinase gastroesphagealvaricealhemorrhageinducedbymetastaticlivertumoroflungcancer
_version_ 1716766169879281664